WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in CYTK — Cytokinetics Inc

CIK 1632972 PLYMOUTH, MN

Position in CYTK

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$812,286

+$227,467 QoQ

Shares Held

9,535

+7.5% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#276

of 477 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. CYTK ranks #32 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$812,286	9,535	+7.5%	Shares	Sole	2026-07-15
2026-03-31	$584,819	8,873	-11.1%	Shares	Sole	2026-04-08
2025-12-31	$634,256	9,982	+1.3%	Shares	Sole	2026-01-08
2025-09-30	$541,685	9,856	+16.3%	Shares	Sole	2025-10-29
2025-06-30	$280,047	8,476	+30.6%	Shares	Sole	2025-07-10
2025-03-31	$260,752	6,488	-31.2%	Shares	Sole	2025-04-16
2024-09-30	$497,904	9,430	-14.9%	Shares	Sole	2024-10-24
2024-06-30	$600,476	11,083	-4.4%	Shares	Sole	2024-07-16
2024-03-31	$812,785	11,593	—	Shares	Sole	2024-04-15
No filing history on record for this holder in this stock.